19-24 As with exenatide, there is minimal risk of hypoglycemia when used with nonsecretagogue medications
Lipo-C + GLP-1 agonists (semaglutide, tirzepatide)
Dietary folic acid supplementation both prior to conception and during pregnancy should be routinely recommended for patients using valproate
Not all the speculation has been cautionary, of course: Morgan Stanley analysts suggest overall healthcare savings associated with GLP-1-related weight loss could top $264 billion by 2035
What Readers Should Discuss With a Clinician Readers considering peptide-related medical decisions should discuss evidence quality, approved alternatives, medical history, current medications, pregnancy or breastfeeding, gastrointestinal risk, pancreatitis history, gallbladder disease, kidney disease, diabetes medications, product legitimacy, and regulatory status with a licensed clinician